4.6 Review

COVID-19 in South Korea

Journal

POSTGRADUATE MEDICAL JOURNAL
Volume 96, Issue 1137, Pages 399-402

Publisher

OXFORD UNIV PRESS
DOI: 10.1136/postgradmedj-2020-137738

Keywords

infectious diseases

Funding

  1. Korea Centers for Disease Control and Prevention [2019-ER5408-00]
  2. Ministry of Health & Welfare, Republic of Korea [HI14C1324]
  3. research grants for deriving the major clinical and epidemiological indicators of people with HIV (Korea HIV/AIDS Cohort Study) [2019-ER5101-00]
  4. Korea Health Promotion Institute [2019-ER5408-00, 2019-ER5101-00] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

A novel coronavirus (severe acute respiratory syndrome-CoV-2) that initially originated from Wuhan, China, in December 2019 has already caused a pandemic. While this novel coronavirus disease (COVID-19) frequently induces mild diseases, it has also generated severe diseases among certain populations, including older-aged individuals with underlying diseases, such as cardiovascular disease and diabetes. As of 31 March 2020, a total of 9786 confirmed cases with COVID-19 have been reported in South Korea. South Korea has the highest diagnostic rate for COVID-19, which has been the major contributor in overcoming this outbreak. We are trying to reduce the reproduction number of COVID-19 to less than one and eventually succeed in controlling this outbreak using methods such as contact tracing, quarantine, testing, isolation, social distancing and school closure. This report aimed to describe the current situation of COVID-19 in South Korea and our response to this outbreak.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available